ASCO Daily News, the official daily news source of the ASCO Annual Meeting, provides comprehensive, accurate, and timely Annual Meeting coverage. ASCO Daily News is available both in print and online, Friday through Tuesday.

The ASCO Daily News e-Digest will bring the news to your inbox each morning to help you stay informed and make the best of your attendee experience at the ASCO Annual Meeting.

News highlights - WRAP UP

2011 ASCO Meeting Theme Reflected in All Aspects of the Program

See highlights of the presentations that particularly illuminate the collective theme of this year's Annual Meeting. Read more

Adjuvant XELOX Shows Promise in Gastric Cancer Based on Improvements in Disease-free Survival

Phase III CLASSIC trial identified a substantial improvement in disease-free survival (DFS) with adjuvant XELOX compared with observation alone following D2 resection. Read more

Randomized Trial Shows No Survival Benefit with Adjuvant Chemotherapy in Ampullary Cancer

The role of adjuvant chemotherapy in patients with ampullary cancer is unknown, and no standard adjuvant treatment has been established. Read more

Study Suggests No Increased Breast Cancer Risk with Hormone Replacement Therapy after Risk-reducing Salpingo-oophorectomy

Study shows no significant difference in the incidence of breast cancer in women who underwent RRSO and received HRT compared with those who underwent RRSO and did not receive HRT, after a mean follow up of 3 to 5 years. Read more

Vemurafenib Improves Outcomes in BRAF-mutated Melanoma

Cabozantinib Shows Unprecedented Activity in Patients with Castration-resistant Prostate Cancer

Antithrombotic Prophylaxis Shown to Provide Clinical Benefit

High-dose Methotrexate Improves Outcome in High-risk B-cell Precursor Acute Lymphoblastic Leukemia

Busulphan/Melphalan Superior to CEM for High-risk Neuroblastoma

Integration of Ipilimumab in the First-line Setting Improves Survival for Patients with Metastatic Melanoma

Three Years of Adjuvant Imatinib May Be the New Standard of Care for High-risk Patients with GIST

Pazopanib Beneficial for Patients with Previously Treated Metastatic Soft Tissue Sarcoma

In Brief

Metformin May Reduce Breast Cancer Risk for Patients with Diabetes

Gene Methylation Profi le Could Predict Oral Cancer Development

HPV-based Screening Could Reduce Burden on Women, Clinicians

Intermittent Androgen Suppression Noninferiority Could Change Treatment of Localized Prostate Cancer

Tamoxifen May Reduce Contralateral Cancers in BRCA Mutation Carriers

Inappropriate Use of Antineoplastic Agents Costing Insurers Millions of Dollars, Driving Up Health Care Costs

Lifestyle Factors as Predictors of Cancer in Women

See also: More News  | More Videos